Cargando…

Modeling Approaches to Predicting Persistent Hotspots in SCORE Studies for Gaining Control of Schistosomiasis Mansoni in Kenya and Tanzania

BACKGROUND: Some villages, labeled “persistent hotspots (PHS),” fail to respond adequately in regard to prevalence and intensity of infection to mass drug administration (MDA) for schistosomiasis. Early identification of PHS, for example, before initiating or after 1 or 2 years of MDA could help gui...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Ye, Sung, Meng-Hsuan, King, Charles H, Binder, Sue, Kittur, Nupur, Whalen, Christopher C, Colley, Daniel G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026890/ https://www.ncbi.nlm.nih.gov/pubmed/31621850 http://dx.doi.org/10.1093/infdis/jiz529

Ejemplares similares

Environmental Predictors of Schistosomiasis Persistent Hotspots following Mass Treatment with Praziquantel
por: Walker, Joseph W., et al.
Publicado: (2020)

Defining Persistent Hotspots: Areas That Fail to Decrease Meaningfully in Prevalence after Multiple Years of Mass Drug Administration with Praziquantel for Control of Schistosomiasis
por: Kittur, Nupur, et al.
Publicado: (2017)

Unprotected water sources and low latrine coverage are contributing factors to persistent hotspots for schistosomiasis in western Kenya
por: Musuva, Rosemary M., et al.
Publicado: (2021)

Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel
por: Kittur, Nupur, et al.
Publicado: (2019)

Discovering, Defining, and Summarizing Persistent Hotspots in SCORE Studies
por: Kittur, Nupur, et al.
Publicado: (2020)

Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood Schistosoma mansoni–Associated Morbidity: A Combined Analysis from the Schistosomiasis Consortium for Operational Research and Evaluation Cohort Studies in the Lake Victoria Regions of Kenya and Tanzania
por: Shen, Ye, et al.
Publicado: (2019)

The Schistosomiasis Consortium for Operational Research and Evaluation 2008–2020: Approaches, Experiences, Lessons, and Recommendations
por: Binder, Sue, et al.
Publicado: (2020)

Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya
por: Ondigo, Bartholomew N., et al.
Publicado: (2018)

Contributions of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) to Schistosomiasis Control and Elimination: Key Findings and Messages for Future Goals, Thresholds, and Operational Research
por: Colley, Daniel G., et al.
Publicado: (2020)

Challenges in Protocol Development and Interpretation of the Schistosomiasis Consortium for Operational Research and Evaluation Intervention Studies
por: King, Charles H., et al.
Publicado: (2020)

SCORE Operational Research on Moving toward Interruption of Schistosomiasis Transmission
por: Campbell, Carl H., et al.
Publicado: (2020)

Schistosomiasis Consortium for Operational Research and Evaluation (SCORE): Its Foundations, Development, and Evolution
por: Colley, Daniel G., et al.
Publicado: (2020)

Comparison of Schistosoma mansoni Prevalence and Intensity of Infection, as Determined by the Circulating Cathodic Antigen Urine Assay or by the Kato-Katz Fecal Assay: A Systematic Review
por: Kittur, Nupur, et al.
Publicado: (2016)

A Persistent Hotspot of Schistosoma mansoni Infection in a Five-Year Randomized Trial of Praziquantel Preventative Chemotherapy Strategies
por: Wiegand, Ryan E, et al.
Publicado: (2017)

Additional Evaluation of the Point-of-Contact Circulating Cathodic Antigen Assay for Schistosoma mansoni Infection
por: Mwinzi, Pauline N. M., et al.
Publicado: (2015)

Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya
por: Abudho, Bernard O., et al.
Publicado: (2020)

Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa
por: King, Charles H., et al.
Publicado: (2020)

Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study
por: Abudho, Bernard O., et al.
Publicado: (2018)

Characteristics of persistent hotspots of Schistosoma mansoni in western Côte d’Ivoire
por: Assaré, Rufin K., et al.
Publicado: (2020)

Control and Elimination of Schistosomiasis as a Public Health Problem: Thresholds Fail to Differentiate Schistosomiasis Morbidity Prevalence in Children
por: Wiegand, Ryan E, et al.
Publicado: (2021)

Reliability of point-of-care circulating cathodic antigen assay for diagnosing schistosomiasis mansoni in urine samples from an endemic area of Brazil after one year of storage at -20 degrees Celsius
por: Favre, Tereza Cristina, et al.
Publicado: (2022)

Influence of Exposure History on the Immunology and Development of Resistance to Human Schistosomiasis Mansoni
por: Black, Carla L., et al.
Publicado: (2010)

Test, Treat, Track, Test, and Treat Active Surveillance toward Elimination of Schistosomiasis: A Feasibility Study
por: Ramzy, Reda M. R., et al.
Publicado: (2020)

SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection
por: King, Charles H., et al.
Publicado: (2020)

La Schistosomiasis Mansoni en Venezuela
por: Tager, M.
Publicado: (1943)

Pseudotumoral form of cerebral Schistosomiasis Mansoni
por: Romero, FR, et al.
Publicado: (2012)

Decline in transmission of schistosomiasis mansoni in Oman
por: Al Abaidani, Idris, et al.
Publicado: (2016)

Impact of Mothers’ Schistosomiasis Status During Gestation on Children’s IgG Antibody Responses to Routine Vaccines 2 Years Later and Anti-Schistosome and Anti-Malarial Responses by Neonates in Western Kenya
por: Ondigo, Bartholomew N., et al.
Publicado: (2018)

Schistosomiasis mansoni incidence data in Rwanda can improve prevalence assessments, by providing high-resolution hotspot and risk factors identification
por: Nyandwi, E., et al.
Publicado: (2017)

Antieosinophil serum and the kinetics of eosinophilia in Schistosomiasis mansoni
Publicado: (1975)

Ectopic Cutaneous Schistosomiasis mansoni in the Sacral Region
por: Raso, Pedro, et al.
Publicado: (2010)

A rapid diagnostic test for schistosomiasis mansoni
por: Mello-Silva, Clélia Christina, et al.
Publicado: (2013)

Schistosomiasis Mansoni Manifesting as Multiple Colonic Polyps
por: Akhtar, Muhammed M, et al.
Publicado: (2020)

Evaluation, Validation, and Recognition of the Point-of-Care Circulating Cathodic Antigen, Urine-Based Assay for Mapping Schistosoma mansoni Infections
por: Colley, Daniel G., et al.
Publicado: (2020)

Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid
por: Riner, Diana K., et al.
Publicado: (2016)

Distribution and abundance of schistosomiasis and fascioliasis host snails along the Mara River in Kenya and Tanzania
por: Dida, Gabriel O., et al.
Publicado: (2014)

Interaction of Biomphalaria cells in primary cultures with Schistosoma mansoni sporocysts
por: Silva-Neto, Aristeu, et al.
Publicado: (2020)

Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries
por: Ezeamama, Amara E., et al.
Publicado: (2016)

Osteopontin Is Upregulated in Human and Murine Acute Schistosomiasis Mansoni
por: Pereira, Thiago Almeida, et al.
Publicado: (2016)

Schistosomiasis Mansoni-Recruited Eosinophils: An Overview in the Granuloma Context
por: Malta, Kássia K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6f37hd2p29ptmvufv2esmldpqr